Page last updated: 2024-11-04

vorinostat and Child Mental Disorders

vorinostat has been researched along with Child Mental Disorders in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Poeta, L1
Padula, A1
Attianese, B1
Valentino, M1
Verrillo, L1
Filosa, S1
Shoubridge, C1
Barra, A1
Schwartz, CE1
Christensen, J1
van Bokhoven, H1
Helin, K1
Lioi, MB1
Collombat, P1
Gecz, J1
Altucci, L1
Di Schiavi, E1
Miano, MG1

Other Studies

1 other study available for vorinostat and Child Mental Disorders

ArticleYear
Histone demethylase KDM5C is a SAHA-sensitive central hub at the crossroads of transcriptional axes involved in multiple neurodevelopmental disorders.
    Human molecular genetics, 2019, 12-15, Volume: 28, Issue:24

    Topics: Animals; Caenorhabditis elegans; Cell Line; DNA-Binding Proteins; Female; HEK293 Cells; Histone Deac

2019